Other financial assets

 
Loans
associates and joint ventures
Other
participations
Other
receivables
Other
deferred
items
Total
      
Balance at 1 January 2015
145
44
45
41
275
      
Changes:
     
- Charged to the income statement
-
(8)
16
-
8
- Capital payments
-
2
-
-
2
- Disposals
-
-
56
-
56
- Loans granted
166
-
2
-
168
- Repayments
(32)
-
(2)
-
(34)
- Consolidation changes
-
4
-
-
4
- Exchange differences
11
1
(3)
2
11
- Transfers
(22)
-
(1)
-
(23)
- Changes in fair value
-
5
-
-
5
- Other
(40)
3
-
(16)
(53)
      
Balance at 31 December 2015
228
51
113
27
419
      
Changes:
     
- Charged to the income statement
-
(9)
3
(6)
(12)
- Capital payments
-
3
-
-
3
- Disposals
-
(3)
2
-
(1)
- Loans granted
31
-
-
-
31
- Repayments
-
-
(4)
2
(2)
- Consolidation changes
-
-
-
-
-
- Exchange differences
3
-
5
1
9
- Transfers
(8)
-
33
(2)
23
- Changes in fair value
-
7
-
-
7
- Other
(1)
1
(16)
2
(14)
      
Balance at 31 December 2016
253
50
136
24
463

For Loans associates and joint ventures, see Note 10 'Associates and joint ventures'.

Other participations relate to equity instruments in companies whose activities support DSM’s business and which can be quoted or unquoted. An amount of €26 million included in Other participations relates to equity instruments, with a fair value that cannot be measured reliably (2015: €32 million). These instruments are therefore measured at cost.

Disposals in 2015 of €56 million relate mainly to the deconsolidation of the bulk chemicals business and the related earn-out receivable.

Transfers include the earn-out of Patheon of €28 million (see Note 10 'Associates and joint ventures').

Other includes €16 million decrease due to divestment settlements (see Note 3 'Changes in the scope of the consolidation' at disposals).